RXi Pharmaceuticals (RXII) - KOL Lunch - The Promise of NeuVax
July 14, 2011
Metropolitan Club
New York, NY
Lowenstein Sandler is a sponsor of a lunch hosted by ROTH Capital Partners and Joseph Pantginis, Ph.D., senior biotechnology analyst, for a discussion with Dr. George Peoples, M.D., principal investigator on NeuVax studies, and Mark Ahn, Ph.D., CEO of RXi.
For more information, click here.
Export to Outlook
 Back to Search Page
|